Two of New Zealand's pharmaceutical industry bodies are merging.
Medicines New Zealand and its vaccine counterpart, the Vaccines Industry Association of New Zealand, will come together under one banner.
Medicines New Zealand will represent all companies involved with the development, production and prescription of medicines and vaccines in New Zealand.
This includes the vaccine branches of bioCSL, GSK, MSD, Novartis and Pfizer.
Medicines New Zealand chairwoman Heather Roy said combining resources would help both organisations achieve a number of shared goals.